Cytophage Technologies Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	0.5	1.52	0.03	2.25
Short-Term Investments	-	0.01	0.01	-
Cash & Short-Term Investments	0.5	1.53	0.04	2.25
Cash Growth	-67.38%	3388.52%	-98.04%	-
Accounts Receivable	0.15	-	-	-
Other Receivables	0.12	0.2	0.34	0.46
Receivables	0.28	0.2	0.34	0.46
Prepaid Expenses	0.11	0.03	0.01	-
Restricted Cash	-	-	2.46	-
Other Current Assets	-	0.06	0.1	0.05
Total Current Assets	0.89	1.82	2.95	2.75
Property, Plant & Equipment	2.45	3.11	2.49	0.94
Total Assets	3.33	4.94	5.44	3.69
Accounts Payable	0.42	0.21	0.36	0.11
Accrued Expenses	-	0.26	0.41	0.02
Short-Term Debt	-	-	0.03	-
Current Portion of Leases	0.24	0.22	0.35	0.11
Other Current Liabilities	-	-	2.5	-
Total Current Liabilities	0.67	0.68	3.64	0.24
Long-Term Leases	1.08	1.32	1.43	-
Total Liabilities	1.75	2.01	5.07	0.24
Common Stock	27.23	25.28	16.18	15.44
Retained Earnings	-30.69	-26.56	-19.09	-14.45
Comprehensive Income & Other	5.05	4.21	3.28	2.46
Shareholders' Equity	1.59	2.93	0.37	3.45
Total Liabilities & Equity	3.33	4.94	5.44	3.69
Total Debt	1.32	1.54	1.8	0.11
Net Cash (Debt)	-0.82	-0	-1.76	2.14
Net Cash Per Share	-0.01	-0.00	-0.04	0.05
Filing Date Shares Outstanding	64.89	53.94	42.81	40.93
Total Common Shares Outstanding	64.89	53.94	42.81	40.93
Working Capital	0.22	1.14	-0.69	2.52
Book Value Per Share	0.02	0.05	0.01	0.08
Tangible Book Value	1.59	2.93	0.37	3.45
Tangible Book Value Per Share	0.02	0.05	0.01	0.08
Machinery	-	1.58	1.26	1.15
Leasehold Improvements	-	1.03	0.05	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.